WilmerHale Counsels Karyopharm Therapeutics in Public Offering of Shares

WilmerHale Counsels Karyopharm Therapeutics in Public Offering of Shares

Firm News

Related Solutions

Leveraging our sophisticated technical, market and legal experience to help clients effectively and efficiently manage complex transactions and get the deal done.
Lawyers with deep and broad experience counseling clients in every industry on the design, implementation, and interpretation of executive compensation arrangements and on general compensation and benefits issues.

Karyopharm Therapeutics Inc., a clinical-stage pharmaceutical company, has announced the closing of its previously announced registered underwritten public offering and the exercise in full of the underwriters' option to purchase additional shares. 

The WilmerHale team counseling Karyopharm was led by Jason Kropp and Steven Singer, and included Bruce Manheim, Kimberly Wethly, Jeffries Oliver-Li, Meghan Walsh, Brett Bromann and Michael Lopes.

Read Karyopharm's press release for more information.

Notice

We appreciate your interest in WilmerHale. While we are pleased to have you contact us, please keep in mind that merely contacting WilmerHale does not create an attorney-client relationship. Such a relationship will not arise until the Firm agrees in writing to represent you in connection with a particular matter. Importantly, unless and until this has occurred, you should not provide us with any confidential information, and we have no duty to keep confidential any information that we may receive from you. Thank you for your understanding.

I Accept Cancel